Skip to main content

Hydroxyethyl Starch in Sodium Chloride Injection Shortage

Last Updated: December 18, 2020
Status: Resolved

Products Affected - Description
    • Voluven (6% tetrastarch in 0.9% sodium chloride) intravenous injection, Pfizer, 6 gram/100 mL, 500 mL flexible container, 20 count, NDC 00409-1029-02 - discontinued
Reason for the Shortage
    • BBraun has Hespan available.
    • Pfizer has 6% hetastarch in 0.9% sodium chloride injection available.
    • Pfizer discontinued Voluven in January 2020.
Available Products
    • 6% hetastarch in 0.9% sodium chloride intravenous injection, Pfizer, 6 gram/100 mL, 500 mL flexible container, 12 count, NDC 00409-7248-03
    • Hespan (6% hetastarch in 0.9% sodium chloride) intravenous injection, BBraun, 6 gram/100 mL, 500 mL flexible container, 12 count, NDC 00264-1965-10

Updated

Updated December 18, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. Created August 16, 2018 by Leslie Jensen, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer